Literature DB >> 3090463

The rapid 'tonic' and the delayed 'induction' components of the prolactin-induced activation of tuberoinfundibular dopaminergic neurons following the systemic administration of prolactin.

K T Demarest, G D Riegle, K E Moore.   

Abstract

The present study was designed to characterize the time and dose relationships of the response of tuberoinfundibular dopaminergic (TIDA) neurons in the rat to systemically administered prolactin (PRL). The activity of TIDA neurons was estimated by measuring the rate of dopamine (DA) synthesis in the median eminence (DOPA accumulation following the administration of a decarboxylase inhibitor). Rats were pretreated with bromocriptine, a dopaminergic agonist, so as to inhibit the release of endogenous PRL from the anterior pituitary, and thereby reduce the activity of TIDA neurons to a 'basal' level from which it could be increased subsequently by exogenously administered PRL. In control animals an intraperitoneal injection of ovine PRL (oPRL) increased DOPA accumulation at 16 h, but not before, whereas in bromocriptine-pretreated animals an intraperitoneal injection of oPRL increased DOPA accumulation after 4 h ('tonic' component) and caused a further increase after 16 h ('induction' component). Continuous intravenous infusions of oPRL into bromocriptine-pretreated rats increased DOPA accumulation in the median eminence by 4 h, and when infused into control rats oPRL reduced serum concentrations of endogenous rat PRL (rPRL) by 2 and 4 h. Continuous intravenous infusions of rPRL increased DOPA accumulation in the median eminence after 2 h; this effect exhibited a very steep dose-response relationship (possibly an 'all-or-none' response). TIDA neurons were very sensitive to changes in circulating concentrations of PRL; their activity was increased if serum PRL concentrations were merely doubled by infusing a low concentration of rPRL for 4 h. Three daily injections of haloperidol elevated circulating rPRL concentrations and increased the rate of DOPA accumulation in the median eminence.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090463     DOI: 10.1159/000124543

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  Calmodulin and a cyclic nucleotide-dependent protein kinase facilitate the prolactin-induced increase in tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons.

Authors:  L A Arbogast
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

2.  Effect of human prolactin administration on gonadotropin and thyrotropin secretion in normal men.

Authors:  M E Molitch; R W Rebar; C P Barsano
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

3.  Prolactin secretory rhythm of mated rats induced by a single injection of oxytocin.

Authors:  Marcel Egli; Richard Bertram; Natalia Toporikova; Michael T Sellix; Wilfredo Blanco; Marc E Freeman
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-03       Impact factor: 4.310

4.  Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration.

Authors:  G A Gudelsky; J I Koenig; T Koyama; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 5.  60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.

Authors:  David R Grattan
Journal:  J Endocrinol       Date:  2015-06-22       Impact factor: 4.286

6.  Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network.

Authors:  Stefanos Stagkourakis; Hoseok Kim; David J Lyons; Christian Broberger
Journal:  Cell Rep       Date:  2016-04-14       Impact factor: 9.423

7.  A Neuro-hormonal Circuit for Paternal Behavior Controlled by a Hypothalamic Network Oscillation.

Authors:  Stefanos Stagkourakis; Kristina O Smiley; Paul Williams; Sarah Kakadellis; Katharina Ziegler; Joanne Bakker; Rosemary S E Brown; Tibor Harkany; David R Grattan; Christian Broberger
Journal:  Cell       Date:  2020-08-06       Impact factor: 41.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.